Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norethisterone vs tranexamic acid vs levonorgestrel intrauterine system for heavy menstrual bleeding
ACTRN12612001055897Phase 4Completed
- Sponsor
- Mine Kiseli
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of norethindrone, tranexamic acid and avatrombopag in hypermenorrhea (3 arms), sponsored by Mine Kiseli. Primary endpoint: Decrease in menstrual blood loss measured by PBAC score. Started May 2005; status: completed.
02
Drugs
norethindronetranexamic acidavatrombopag
03
Conditions
hypermenorrhea
Beyond the preview
Go deeper on ACTRN12612001055897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001055897.